These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22575283)

  • 1. Actions of the Kunitz-type serine protease inhibitor Amblyomin-X on VEGF-A-induced angiogenesis.
    Drewes CC; Dias RY; Hebeda CB; Simons SM; Barreto SA; Ferreira JM; Chudzinski-Tavassi AM; Farsky SH
    Toxicon; 2012 Sep; 60(3):333-40. PubMed ID: 22575283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells.
    Drewes CC; Dias RY; Branco VG; Cavalcante MF; Souza JG; Abdalla DS; Chudzinski-Tavassi AM; Farsky SH
    Toxicon; 2015 Jul; 101():1-10. PubMed ID: 25912945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick troponin I-like molecule is a potent inhibitor for angiogenesis.
    Fukumoto S; Sakaguchi T; You M; Xuan X; Fujisaki K
    Microvasc Res; 2006 May; 71(3):218-21. PubMed ID: 16631826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
    Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
    Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-X.
    Pacheco MT; Berra CM; Morais KL; Sciani JM; Branco VG; Bosch RV; Chudzinski-Tavassi AM
    PLoS One; 2014; 9(12):e111907. PubMed ID: 25479096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
    Ayalasomayajula SP; Ashton P; Kompella UB
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells.
    Schmidt MCB; Morais KLP; Almeida MES; Iqbal A; Goldfeder MB; Chudzinski-Tavassi AM
    Cell Adh Migr; 2020 Dec; 14(1):129-138. PubMed ID: 30238848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.
    Cho SG; Yi Z; Pang X; Yi T; Wang Y; Luo J; Wu Z; Li D; Liu M
    Cancer Res; 2009 Sep; 69(17):7062-70. PubMed ID: 19671799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic properties of calcium trifluoroacetate.
    Bussolati B; Ribatti D; Munaron L; Bartorelli A; Bussolati G
    Microvasc Res; 2009 Dec; 78(3):272-7. PubMed ID: 19631669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model.
    de Souza JG; Morais KL; Anglés-Cano E; Boufleur P; de Mello ES; Maria DA; Origassa CS; de Campos Zampolli H; Câmara NO; Berra CM; Bosch RV; Chudzinski-Tavassi AM
    Oncotarget; 2016 Sep; 7(38):62255-62266. PubMed ID: 27566592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R; Dai Y; Gao XH; Lu D; Xia YF
    Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo.
    Branco VG; Iqbal A; Alvarez-Flores MP; Sciani JM; de Andrade SA; Iwai LK; Serrano SM; Chudzinski-Tavassi AM
    Biochim Biophys Acta; 2016 Oct; 1864(10):1428-35. PubMed ID: 27479486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a Chinese herbal health formula, "Gan-Lu-Yin", on angiogenesis.
    Pan CH; Hsieh IC; Liu FC; Hsieh WT; Sheu MJ; Koizumi A; Wu CH
    J Agric Food Chem; 2010 Jul; 58(13):7685-92. PubMed ID: 20527984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.